The clinical trials below are available in the specialty you selected. Choose a different specialty.
Seeking HIV-positive adults who use marijuana for a research study
Researchers at Duke University Medical Center in Durham, NC, are conducting a study on HIV/AIDS and marijuana use. If you qualify for participation, you could earn up to $180 for three study visits.
You may be eligible to participate if you are:
- 18 years or older
- Using marijuana
For more information call the study coordinator at 919-681-7864 and mention Project Brain: Reloaded.
Your participation is strictly voluntary and confidential. (REF# Pro00016338)
Strategic Timing of Antiretroviral Therapy (START)
HIV patients are needed for a study examining the most effective time to begin antiretroviral treatment. (REF# 27264)
Treatment Experienced Bristol-Meyers Squibb (BMS) Study
This is a phase IIb randomized, controlled, partially-blinded trial to investigate safety, efficacy, and dose-response of BMS-663068 in tx experienced HIV-1 subjects, followed by an open-label period on the recommended dose. (REF# 31249)
Impulsivity and Behavioral Risk in HIV Patients with Mood Disorders
We are conducting a study on impulsivity, HIV/AIDS, and mood disorders like depression or bipolar (manic-depression).
Effect of HDL-Raising Therapies on HIV Subjects with Low HDL Cholesterol (A5293)
HIV-infected people with low levels of high-density lipoprotein cholesterol (HDL-C) and elevated triglycerides are needed for a study comparing HDL-C raising medications. (REF# 31384)